Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00697827 · ClinicalTrials.gov registry record · Phase 3
A Study of the In-Space Device for Treatment of Moderate Spinal Stenosis
A Phase 3 study, sponsored by Synthes USA HQ.
- Terminated
- Registry status
- Phase 3
- Development phase
- 44
- Enrollment target
NCT00697827 is a Phase 3 study that was terminated before completion, run by Synthes USA HQ. The registered enrollment target is 44 participants.
The verdict
NCT00697827, a Phase 3 study, was terminated before completion, sponsored by Synthes USA HQ.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the In-Space compared to the X STOP Interspinous Process Distraction (IPD) device ("X STOP") for the treatment of patients experiencing intermittent neurogenic claudication secondary to moderate degenerative lumbar stenosis at one or two lumbar levels.
Interventions
- DEVICE Interspinous Spacer device
- DEVICE Interspinous Process Distraction Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00697827
The ClinicalTrials.gov registry entry for NCT00697827 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Synthes USA HQ, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Interspinous Spacer device is the first listed.
NCT00697827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00697827 about?
NCT00697827 is a clinical study titled "A Study of the In-Space Device for Treatment of Moderate Spinal Stenosis". The purpose of this study is to evaluate the safety and effectiveness of the In-Space compared to the X STOP Interspinous Process Distraction (IPD) device ("X STOP") for the treatment of patients experiencing intermittent neurogenic claudication secondary to moderate degenerative lumbar stenosis at ...
What is the current status of trial NCT00697827?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2008-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00697827?
The interventions under investigation include: Interspinous Spacer device (DEVICE), Interspinous Process Distraction Device (DEVICE).
Who is sponsoring clinical trial NCT00697827?
This trial is sponsored by Synthes USA HQ, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.